| Rebecca Cleveland, CCC-SLP | |
|
4441 Diplomacy Dr, Anchorage, AK 99508-5910 | |
| (907) 561-8060 | |
| (907) 563-3172 |
| Full Name | Rebecca Cleveland |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4441 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518630391 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 179656 (Alaska) | Secondary |
| 235Z00000X | Speech-language Pathologist | 197414 (Alaska) | Primary |
| Provider Name | Alaska Native Tribal Health Consortium |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
The report will offer the Institute of Medicine's recommendations regarding how the health law's essential benefits package should be determined. In other health law news, federal regulators also must decide whether family planning should be included as a preventive care benefit. Religious groups say the "carve-out" exemption included in the draft regulations is too narrow.
Allergan plc today announced that it has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam.
A simple, five-question patient-administered survey (COPD-PS) may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD).
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy. This marketing authorization represents the first regulatory approval of REVLIMID in Japan.
Sometimes there is a fine ethical line between legislative maneuvering and bribery. At other times, that line is crossed by a speeding, honking tractor-trailer, with outlines of shapely women on mud flaps bouncing as it rumbles past (Michael Gerson, 12/23).
› Verified 5 days ago
| Provider Name | Southcentral Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
The report will offer the Institute of Medicine's recommendations regarding how the health law's essential benefits package should be determined. In other health law news, federal regulators also must decide whether family planning should be included as a preventive care benefit. Religious groups say the "carve-out" exemption included in the draft regulations is too narrow.
Allergan plc today announced that it has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam.
A simple, five-question patient-administered survey (COPD-PS) may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD).
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy. This marketing authorization represents the first regulatory approval of REVLIMID in Japan.
Sometimes there is a fine ethical line between legislative maneuvering and bribery. At other times, that line is crossed by a speeding, honking tractor-trailer, with outlines of shapely women on mud flaps bouncing as it rumbles past (Michael Gerson, 12/23).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Cleveland, CCC-SLP 7033 E Tudor Rd Ste 103, Anchorage, AK 99507-1262 Ph: (907) 729-8961 | Rebecca Cleveland, CCC-SLP 4441 Diplomacy Dr, Anchorage, AK 99508-5910 Ph: (907) 561-8060 |
News Archive
The report will offer the Institute of Medicine's recommendations regarding how the health law's essential benefits package should be determined. In other health law news, federal regulators also must decide whether family planning should be included as a preventive care benefit. Religious groups say the "carve-out" exemption included in the draft regulations is too narrow.
Allergan plc today announced that it has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam.
A simple, five-question patient-administered survey (COPD-PS) may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD).
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy. This marketing authorization represents the first regulatory approval of REVLIMID in Japan.
Sometimes there is a fine ethical line between legislative maneuvering and bribery. At other times, that line is crossed by a speeding, honking tractor-trailer, with outlines of shapely women on mud flaps bouncing as it rumbles past (Michael Gerson, 12/23).
› Verified 5 days ago
Kathryn Cross, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12350 Industry Way, 202, Anchorage, AK 99515 Phone: 907-301-4588 | |
Tracey Keaton, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6927 Old Seward Hwy Ste 100, Anchorage, AK 99518 Phone: 907-345-0050 | |
Christal Hays, MS CCC SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4441 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-8800 | |
Mrs. Lisa J.c. Rayes, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4048 Laurel St Ste 303, Anchorage, AK 99508 Phone: 907-562-4550 | |
Lian Liew Tan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4155 Tudor Centre Dr, Suite #103, Anchorage, AK 99508 Phone: 907-854-8624 | |
Mrs. Yvonne Marie San Juan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4241 B St Ste 301, Anchorage, AK 99503 Phone: 907-727-0935 Fax: 907-276-7529 | |
Speak From The Heart Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3351 W 84th Ave, Anchorage, AK 99502 Phone: 907-390-0492 |